Tenofovir use and pregnancy among women initiating HAART

AIDS

Volumn 26, Issue 18, 2012, Pages 2393-2397

  Maskew, Mhairi ^a   Westreich, Daniel ^b,d   Firnhaber, Cindy ^a,c   Sanne, Ian ^a,c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RIGHT TO CARE   (South Africa)

^d DUKE UNIVERSITY   (United States)

Author keywords

antiretroviral therapy; epidemiology; pregnancy; tenofovir; women's health

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LOPINAVIR; NEVIRAPINE; STAVUDINE; TENOFOVIR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DRUG USE; FEMALE; FOLLOW UP; HAZARD RATIO; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SOUTH AFRICA; WOMEN'S HEALTH;

ADENINE; ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MIDDLE AGED; ORGANOPHOSPHONATES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SOUTH AFRICA; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 84870240375     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328359a95c     Document Type: Article

References (11)

1. Pettifor AE, Rees HV, Kleinschmidt I, Steffenson AE, Mac Phail C, Hlongwa-Madikizela L, et al. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS 2005;19:1525-1534. (Pubitemid 41400699)
2. UNAIDS/WHO. AIDS Epidemic Update 2007. Geneva, Switzerland: WHO; 2007. http://data.unaids.org/pub/epislides/2007/2007-epiupdate-en.pdf [Accessed 9 September 2012].
3. Myer L, Carter RJ, Katyal M, Toro P, El-Sadr WM, Abrams EJ. Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS Med 2010;7:e1000229.
4. FHI360. FEM-PrEP Project. Research Triangle Park, North Carolina; 2011. http://www.fhi360.org/en/Research/Projects/FEM-PrEP.htm [Accessed 24 February 2012].
5. Sibeko S, Baxter C, Yende N, Karim QA, Karim SS. Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial. Obstet Gynecol 2011;118:895-904.
6. FHI360. Pregnancy and contraceptive effectiveness in the FEM-PrEP Trial. Research Triangle Park, North Carolina: 2011. http://www.fhi360.org/en/Research/ Projects/FEM-PrEP.htm [Accessed 24 February 2012].
7. Fox MP, Maskew M, Macphail AP, Long L, Brennan AT, Westreich D, et al. Cohort Profile: The Themba Lethu Clinical Cohort, Johannesburg, South Africa. Int J Epidemiol 2012 [Epub ahead of print].
8. Howe CJ, Cole SR, Westreich DJ, Greenland S, Napravnik S, Eron JJ. Splines for trend analysis and continuous confounder control. Epidemiology 2011;22:874-875.
9. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000;11:550-560. (Pubitemid 30660034)
10. Westreich D, Cole SR. Invited commentary: positivity in practice. Am J Epidemiol 2010;171:674-677; discussion 678-681.
11. WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendations for a public health approach. Geneva, Switzerland: WHO; 2010. www.who.int/hiv/pub/mtct/antiretroviral2010 [Accessed 9 September 2012].